ANDA 206729, held by Micro Labs. Nebivolol Hydrochloride.
As of Nov 21, 2026, ANDA 206729 (Nebivolol Hydrochloride), held by Micro Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 28, 2020 | Original application | Tentative approval | None posted |
| Nebivolol Hydrochloride2.5MG · tablet;oral | Nebivolol Hydrochloride | None (tentative approval) |
| Nebivolol Hydrochloride5MG · tablet;oral | Nebivolol Hydrochloride | None (tentative approval) |
| Nebivolol Hydrochloride10MG · tablet;oral | Nebivolol Hydrochloride | None (tentative approval) |
| Nebivolol Hydrochloride20MG · tablet;oral | Nebivolol Hydrochloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters